Marvell Technology’s Divergent Signals: Record Growth, a $12 Billion Google Deal, and a 35% Monthly Drop

The analyst community is tearing itself in two over Marvell Technology. KeyBanc just slapped a $400 price target on the stock — the highest on Wall Street — citing a $12 billion custom-chip deal with Google and the looming production ramp of Amazon’s Trainium-3 processor. Yet the Erste Group Bank downgraded the shares to “Hold” from “Buy”, warning that a price-to-earnings ratio of roughly 73 — nearly three times the industry median of 26 — is impossible to justify when the company depends on a handful of hyperscaler customers. The result? An equity caught between a long-term growth story and a short-term valuation reckoning.

The price action tells that story in brutal numbers. On Friday, Marvell closed at €165.12, up a modest 0.3% on the day. But that calm masks a weekly decline of 20% and a monthly collapse of nearly 35%. From the all-time high of €290.35 reached on June 3, the stock has now surrendered 43% of its value. The 50-day moving average sits at €209.38 — 21% above the current price — a flashing warning for short-term traders. Yet the 200-day average of €113.57 still offers a cushion of more than 45%, and the annualized 30-day volatility of nearly 99% underscores the two-way risk.

The sell-off was triggered in part by the Erste downgrade, but the broader context is a sector-wide nervousness over hyperscaler capital expenditure plans. Reports of revised spending trajectories at the big cloud providers have hit custom-silicon names especially hard, and Marvell has taken the brunt. Industry observers now talk of a “mid-cycle reset” for semiconductors, even as equipment revenue is expected to hit fresh records by 2028. The structural demand for AI infrastructure hasn’t evaporated, but investors are punishing any sign that the pace of orders might slow.

Marvell’s own financials, however, tell a different story. The company reported record revenue of $2.4 billion in its fiscal first quarter and guided for $2.7 billion in the second quarter — year-over-year growth of roughly 35%. Gross margins are seen in a range of 52.1% to 53.1%, with adjusted earnings of about $0.93 per share. For the full year, the stock has still more than doubled, and anyone who bought a year ago is sitting on a gain of 166%. The paradox could almost be called schizophrenic: a company in structural ascent losing a third of its market value in four weeks.

Should investors sell immediately? Or is it worth buying Marvell Technology?

KeyBanc’s bullish thesis rests on two concrete developments. The Google chip deal, code-named “Merope,” is reportedly worth up to $12 billion and represents a multi-year revenue stream. The Amazon Trainium-3 processor is set to enter production ramp in the second half of 2026, adding another growth leg. These are not speculative hopes but signed contracts and scheduled manufacturing milestones. The broader analyst consensus remains decidedly bullish: S&P Global tracks 43 analysts who rate the stock a “Strong Buy” on average, with a mean price target of $252.56 — implying a 34% upside from current levels. But the dispersion is wide, from a low of $110 to KeyBanc’s $400.

Technical indicators reflect the severity of the decline. The relative strength index sits at 35.3, nearing oversold territory where counter-moves have historically been more frequent. The stock is 43% below its 52-week high. A quarterly dividend of $0.06 per share, with an ex-dividend date of July 10, offers a small but reliable anchor for long-term holders amid the turbulence.

What happens next depends largely on the earnings calendar. Arista Networks, a rival often used as a benchmark, reports on August 4. Marvell itself will release its results later in August. Those reports will show whether the operational momentum can overpower the valuation concerns. For now, the market is pricing in a narrative of caution, while KeyBanc and others are betting on a story of execution. The next few weeks will determine which side is right.